Otologic Pharmaceutics

Private

Oklahoma City, OklahomaHealthcare & Life Scienceshttps://otologicpharma.com

Last Round

Grant

Jul 30, 2020

Total Funding Raised

$11.7M

Company Overview

Otologic Pharmaceutics is a biopharmaceutical company that develops treatments for acute and chronic hearing loss.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

hearing loss therapeuticshearing loss drugclinical-stage biopharmanoise-induced hearing lossNIHLhair cell regenerationhearing restorationsiRNA therapyregenerative medicinetinnitus treatmentage-related hearing lossotologydrug licensinghearing preservationDoD medical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Otologic Pharmaceutics Comps

Public and private peers based on sector, stage, and business model.

Otologic Pharmaceutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Otologic Pharmaceutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 30, 2020
Grant	Oct 1, 2017
Grant	Nov 19, 2014
Series A	Apr 3, 2014

View all Funding Rounds

Key People

Founding team and executive leadership

Gareth Willis

Chief Operating Officer

Executive Team

Otologic Pharmaceutics Investors

Notable investors and investment history

Otologic Pharmaceutics investors
Investor	Rounds
i2E	Series A
Oklahoma Life Science Fund	Series A
United States Department of Defense	Grant
Presbyterian Health Foundation	Series A
Oklahoma Center for the Advancement of Science and Technology	Grant

View all Investors

Otologic Pharmaceutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Otologic Pharmaceutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Otologic Pharmaceutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOklahoma City, Oklahoma

Employee Range2

Year Founded2009

Last FundingJul 30, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.